Reshmona Pharmaceuticals Llp - Company Profile

It is a chemicals limited liability partnership based in Pune, Maharashtra, India, established in 2018.
2018 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Reshmona Pharmaceuticals Llp

Reshmona Pharmaceuticals Llp, a active limited liability partnership, was established on 25 October 2018 in Pune, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds LLPIN: AAN-4776. Registered under ROC Roc Pune. It has total obligation of contribution of ₹50.00 K .

Its leadership includes Manjiri Satish Pandit (Designated Partner), Mona Rohan Dahibhate (Designated Partner). Past directors included Ajay Kumar Pandey. Its latest date of accounts and solvency statement 31 March 2020. It is based at Fl-4 Runwal Sukun, Fno.4, Green P Ark Socy. Lane-2, Aundhpune Baner, Pune, Maharashtra, 411021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAN-4776

  • Incorporation Date

    25 October 2018

  • Total Obligation of Contribution

    ₹50.00 K

  • ROC Code

    Roc Pune

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 50.00 K
  • Company Age 7 Year, 6 Months
  • Last Filing with ROC 31 Mar 2020
Company report

Reshmona Pharmaceuticals Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Reshmona Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Reshmona Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Manjiri Satish Pandit Designated Partner 30 Jun 2021 Current
Mona Rohan Dahibhate Designated Partner 25 Oct 2018 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 30 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Reshmona Pharmaceuticals Llp.

Enhance accessibility to Reshmona Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Reshmona Pharmaceuticals Llp revenue growth over time
Reshmona Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Reshmona Pharmaceuticals Llp?

Unlock access to Reshmona Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Reshmona Pharmaceuticals Llp?

Unlock and access historical data on people associated with Reshmona Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Reshmona Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reshmona Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Reshmona Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Reshmona Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Director Appointment

    Manjiri Satish Pandit was appointed as a Designated Partner was appointed as a Designated Partner on 30 Jun 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.

  • Statement of Assets & Liabilities

    The activity Reshmona Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune. was completed.

  • Director Appointment

    Progress on Mona Rohan Dahibhate was appointed as a Designated Partner was appointed as a Designated Partner on 25 Oct 2018 & has been associated with this company since 7 years 6 months . was documented.

  • LLP Incorporation

    Progress on Reshmona Pharmaceuticals Llp was registered on 25 Oct 2018 with Roc Pune & aged 7 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Reshmona Pharmaceuticals Llp?

The LLPIN of Reshmona Pharmaceuticals Llp is AAN-4776.

Where is Reshmona Pharmaceuticals Llp headquartered?

Reshmona Pharmaceuticals Llp is headquartered at Fl-4 Runwal Sukun, Fno.4, Green P Ark Socy. Lane-2, Aundhpune Baner, Pune, Maharashtra, 411021.

When was Reshmona Pharmaceuticals Llp incorporated?

Reshmona Pharmaceuticals Llp was incorporated on 25 October 2018.

Who are the current directors of Reshmona Pharmaceuticals Llp?

The current directors of Reshmona Pharmaceuticals Llp are

What is the primary industry of Reshmona Pharmaceuticals Llp?

The primary industry of Reshmona Pharmaceuticals Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available